Elanco Animal Health Incorporated
ELAN
Kedudukan dalam Saham
#1817
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Harga Saham
$23.54
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$11.76B
Perubahan (1 hari)
0.17%
Perubahan (1 tahun)
9.90%
Negara
US
Perdagangan Elanco Animal Health Incorporated (ELAN)
Kategori
Healthcare
EPS untuk Elanco Animal Health Incorporated (ELAN)
EPS setakat June 2026 TTM: $-0.41
Menurut laporan kewangan terkini dan harga saham Elanco Animal Health Incorporated, EPS semasa syarikat (TTM) adalah $-0.41. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-2.50 peningkatan berbanding EPS tahun 2022 iaitu $-0.15.
Sejarah EPS untuk Elanco Animal Health Incorporated dari 2015 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-0.41 | -160.29% |
| 2024 | $0.68 | -127.20% |
| 2023 | $-2.50 | 1,566.67% |
| 2022 | $-0.15 | -84.54% |
| 2021 | $-0.97 | -23.62% |
| 2020 | $-1.27 | -805.56% |
| 2019 | $0.18 | -35.71% |
| 2018 | $0.28 | -132.18% |
| 2017 | $-0.87 | 569.23% |
| 2016 | $-0.13 | -77.97% |
| 2015 | $-0.59 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -235.68% |
IN
|
